ClinicalTrials.gov
ClinicalTrials.gov Menu

Caregiver Assessments of the Quality of Home Hospice Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00895024
Recruitment Status : Active, not recruiting
First Posted : May 7, 2009
Last Update Posted : August 11, 2017
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

Brief Summary:

The Objectives are to administer the Family Evaluation of Hospice Care (FEHC) questionnaire and The Texas Revised Inventory of Grief (TRIG) to caregivers previously enrolled into the parent grant and conduct supplemental analyses to:

  1. examine cross-ethnic differences in the caregivers' quality of hospice care assessments.
  2. investigate the association between parenteral hydration status of the patient and the quality of care assessments provided by the caregivers after death.
  3. examine the association between levels of grief (as measured by the TRIG) and the quality of hospice care assessments provided by the caregiver.

Condition or disease Intervention/treatment
Advanced Cancer Behavioral: Phone Interview/Questionnaire

Detailed Description:

After the death of their loved-ones, caregivers will be asked to report on the care received by their care recipient and the quality of practical and emotional care provided to them by hospice by completing the 25-minute FEHC questionnaire over the phone. Caregivers will also be asked 16 additional questions to assess their attitudes and beliefs about hydration at the end of life, and a brief questionnaire to assess past and current levels of grief (TRIG). The additional questions on hydration and grief can easily be completed in less than 10 minutes over the phone. The entire interview should take no more than 35 minutes to complete.

Bereaved caregivers who have participated in the parent grant and have lost their loved one within 3-23 months will be mailed a letter from Drs. Bruera and Torres inviting them to participate in the voluntary supplemental after-death survey. The letter will include a brief description of the research study and appropriate contact information for the caregiver to call if she/he is interested in participating. The letters then will be followed up by a phone call from Dr. Torres to verify receipt of the letter. If the caregivers express their interest in participating in the study, they will be asked a few screening questions over the phone to verify their eligibility. Once found eligible for the study, a telephone verbal consent will be obtained.

Dr. Isabel Torres will conduct the phone interviews with 128 primary caregivers who had previously completed the parent grant protocol.


Study Type : Observational
Estimated Enrollment : 128 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Caregiver Assessments of the Quality of Home Hospice Care: A Comparison Across 3 Ethnic Groups (A Preliminary Study)
Actual Study Start Date : April 2009
Estimated Primary Completion Date : April 2019
Estimated Study Completion Date : April 2019

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
Caregivers Behavioral: Phone Interview/Questionnaire
35-minute questionnaire over the phone.
Other Name: Survey



Primary Outcome Measures :
  1. Survey assessment of cross-ethnic differences in caregivers' quality of hospice care [ Time Frame: 3-23 Months After Hospice Care ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Bereaved family caregivers who completed their participation in the UT MDACC parent protocol (2006-0494) and have lost their loved one within 3-23 months. Caregivers who participated in the parent grant met the inclusion/exclusion criteria of the parent grant.
Criteria

Inclusion Criteria:

  1. Bereaved family caregivers who completed their participation in the parent protocol (2006-0494) and have lost their loved one within 3-23 months.
  2. Caregivers who participated in the parent grant met the inclusion/exclusion criteria of the parent grant.

Exclusion Criteria:

  1. Bereaved family caregivers who did not complete their participation in the parent protocol or any other caregiver who was never enrolled in the parent protocol (2006-0494).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00895024


Locations
United States, Texas
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Investigators
Principal Investigator: Isabel Torres, MPH, DRPH M.D. Anderson Cancer Center

Additional Information:
Responsible Party: M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier: NCT00895024     History of Changes
Other Study ID Numbers: 2009-0031
First Posted: May 7, 2009    Key Record Dates
Last Update Posted: August 11, 2017
Last Verified: August 2017

Keywords provided by M.D. Anderson Cancer Center:
Caregiver
Questionnaire
Home Hospice Care
Family Evaluation of Hospice Care
FEHC
The Texas Revised Inventory of Grief
TRIG
Cross-ethnic differences
Parenteral Hydration
Grief